How to use Efudix and calcipotriol: a step-by-step guide
How to apply the four-day Efudix and calcipotriol combination for actinic keratoses, what the skin reaction looks like day by day, and when to seek advice.
The short answer: apply a thin layer of Efudix cream, then straight away the same amount of calcipotriol ointment on top, and rub both in. Do this morning and night for four days, on an area no bigger than 5 cm × 5 cm unless I have told you otherwise. Expect the skin to go red and crusty, with the reaction peaking a few days after you stop. It usually settles within about two weeks.
This guide is for patients I have prescribed the four-day Efudix and calcipotriol combination for actinic keratoses (sun damage). If you’d like to know why the combination works and why it only takes four days, read Can a four-day cream treatment clear sun damage?
At a glance
| Medicines | Efudix (5% fluorouracil) cream and calcipotriol 50 microgram/g ointment |
|---|---|
| Used for | Actinic keratoses: rough, scaly, sun-damaged patches |
| How often | Twice a day, morning and night |
| How long | 4 days (8 applications), unless I advise otherwise |
| Area | No more than 5 cm × 5 cm per treatment, unless I advise otherwise |
| Reaction | Expected. Peaks after you stop and usually settles in about 2 weeks |
Before you start
- Know the area. Be clear exactly which patch of skin to treat. A photo on your phone taken at your appointment helps.
- Plan the timing. The skin will look red and crusty for up to two weeks. Avoid starting just before a holiday, sunny weather or a special occasion.
- Tell me if you are pregnant, trying to conceive or breastfeeding, are allergic to either medicine, or have ever reacted badly to fluorouracil chemotherapy.
- Have ready: a soap-free wash, an unopened tub of petroleum jelly and a broad-spectrum SPF 30+ sunscreen.
How to apply it, step by step
- Wash your hands thoroughly.
- Clean and dry the area to be treated.
- Apply Efudix first. Spread a thin layer over the treatment area only.
- Apply calcipotriol straight away. Don’t wait. Put roughly the same amount of calcipotriol ointment over the same area, so the two mix in about equal quantities.
- Rub both in well.
- Wash your hands again.
- Repeat in the evening, ideally at the same times each day, for four days.
A few tips:
- A thin layer is enough. Using more doesn’t work better, it just makes the skin more irritated.
- If the sun damage is widespread, I may ask you to treat one section at a time and move on to the next area later.
- Don’t apply it to your eyelids or lips, and keep it away from your eyes, mouth and nose.
- Don’t apply it to open cuts or broken skin.
- Don’t cover the area with a dressing unless I have told you to.
What to expect, day by day
| When | What you might notice |
|---|---|
| Days 1–4 (applying) | Some redness, warmth or stinging may start. Keep applying the creams. |
| Days 5–10 (stopped) | The reaction builds and usually peaks: redness, swelling, crusting and sometimes weeping. This is normal and shows the treatment is working. |
| Around day 11 | The skin often starts to peel. |
| Around 2 weeks | Most skin is back to normal, or close to it. |
The more sun damage there is, the stronger the reaction. Patches that looked normal before can light up during treatment. This is sun damage that wasn’t visible yet, and it’s being treated too.
Looking after your skin
- You can wash the area as normal throughout.
- If the skin gets very irritated, wash it gently with water and a soap-free wash, pat it dry, then apply petroleum jelly with a clean fingertip. Use a fresh, unopened tub to reduce the risk of infection.
- Protect the area from the sun during treatment and until it has healed: SPF 30+ broad-spectrum sunscreen, a wide-brimmed hat and covering clothing. Sunlight makes the reaction worse.
- Avoid make-up, perfumed products and other creams on the treated skin until it has healed.
When to stop and get advice
Stop the creams and contact me if the reaction is very severe, very painful or more than you can tolerate.
Get medical advice promptly if you notice:
- Signs of infection: increasing pain, pus, spreading redness or yellow crusting
- Stomach cramps, diarrhoea, vomiting, a sore or swollen tongue, mouth ulcers or a fever
- A rash spreading beyond the treated area
Call 999 or go to A&E if you have signs of a severe allergic reaction: swelling of the face, lips, tongue or throat, difficulty breathing or severe dizziness.
Rare side effects
- An ulcer, which can leave a change in skin colour or a scar. This is more likely on the lower legs.
- Raised blood calcium from using too much calcipotriol. Don’t use more than 100 g of calcipotriol in a week. This is very unlikely on a four-day course.
Safety at home
- Keep both medicines out of reach of children and pets.
- Pets: fluorouracil can be seriously harmful, even fatal, to animals. Don’t let pets lick the treated skin, wash your hands before handling them and dispose of tubes safely.
- If anyone swallows either medicine, go to your nearest A&E and take the packaging with you.
Quick checklist
- I know exactly which area to treat
- Efudix first, calcipotriol straight after, in equal thin layers
- Twice a day for four days
- Hands washed before and after
- Sun protection every day until healed
- I know the reaction will peak after I stop
Next steps
If you have rough, scaly patches on sun-exposed skin, or have questions about your treatment, book a consultation at The Ü Clinic in Sevenoaks or Oxted. If a patch is growing, bleeding or tender, it should be checked to rule out skin cancer. You can read more on my squamous cell carcinoma treatment page.
This guide is general information and doesn’t replace the instructions you were given at your appointment.
Sources
- The Royal Marsden NHS Foundation Trust. 5% 5-fluorouracil cream (Efudix) and calcipotriol ointment combination treatment. Patient information SM-1820-01, 2023.
- British Association of Dermatologists. 5-fluorouracil cream: patient information leaflet.
- Cunningham TJ, et al. Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy. Journal of Clinical Investigation 2017;127:106–16.
